Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hodgkin Disease × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Obesity 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Inflammation 1 Hodgkin Disease 1 Chemotherapy Effect 1

Interventions

Cyclophosphamide 10 Nivolumab 7 pembrolizumab 6 fludarabine 6 Gemcitabine 6 Brentuximab Vedotin 6 Etoposide 5 Doxorubicin 5 Dexamethasone 5 Dacarbazine 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Vinblastine 4 Mycophenolic Acid 4 Melphalan 4 Filgrastim 4 Blood Specimen Collection 4 Vinorelbine 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cytarabine 3 pegfilgrastim 2 X-Rays 2 Vincristine 2 Tacrolimus 2 Stem Cell Transplantation 2 Rituximab 2 Cisplatin 2 Carmustine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡